Literature DB >> 2339672

Drug actions on delayed-type hypersensitivity in rats with developing and established adjuvant arthritis.

P Hambleton1, S McMahon.   

Abstract

Rats were sensitized by i.d. injection in the base of the tail with Freund's complete adjuvant (FCA) and were challenged i.d. in the dorsal skin with mycobacterial antigen. The 24 hour dermal delayed-type hypersensitivity (DTH) response increased up to 10 days after FCA injection followed by a decrease by day 15 which coincided with the development of adjuvant arthritis (AA). Drug studies were performed, using a 4-day dosing schedule, on optimal DTH elicited on day 10, suboptimal DTH elicited on day 15, and AA (day 16). Cyclosporine, leflunomide and prednisolone significantly inhibited day 10 DTH and AA with no effect on day 15 DTH. Indomethacin and tiaprofenic acid significantly inhibited AA with no effect on either DTH response. Chloroquine, levamisole, D-penicillamine, diazepam and RU38468 had no significant effect on DTH or AA. These findings suggest a complex temporal relationship between AA, DTH and drug actions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2339672     DOI: 10.1007/bf01966465

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  24 in total

Review 1.  Stress and immunity: an integrated view of relationships between the brain and the immune system.

Authors:  R Dantzer; K W Kelley
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

2.  Pharmacologic characterization of the antiinflammatory properties of a new dual inhibitor of lipoxygenase and cyclooxygenase.

Authors:  M J DiMartino; D E Griswold; B A Berkowitz; G Poste; N Hanna
Journal:  Agents Actions       Date:  1987-02

3.  Antibody to mycobacterial antigens in adjuvant arthritis (AA). I. Relationship to disease and delayed hypersensitivity.

Authors:  R J Perper; A L Oronsky; V Blancuzzi
Journal:  Arthritis Rheum       Date:  1972 May-Jun

4.  The effect of some antirheumatic drugs in vivo on the response of spleen cells to concanavalin A in rats with chronic inflammation.

Authors:  L Binderup; E Bramm; E Arrigoni-Martelli
Journal:  Int J Immunopharmacol       Date:  1982

5.  Effect of adjuvant disease in rats on cyclophosphamide and isophosphamide metabolism.

Authors:  F J Beck; M W Whitehouse
Journal:  Biochem Pharmacol       Date:  1973-10-01       Impact factor: 5.858

6.  The role of immunity to cartilage proteoglycan in adjuvant arthritis. Intravenous injection of bovine proteoglycan enhances adjuvant arthritis.

Authors:  R F Van Vollenhoven; A Soriano; P E McCarthy; R L Schwartz; F C Garbrecht; G J Thorbecke; G W Siskind
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

7.  Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity--I. Disease modifying action on adjuvant arthritis of the rat.

Authors:  R R Bartlett; R Schleyerbach
Journal:  Int J Immunopharmacol       Date:  1985

8.  Immunological abnormalities in rats with adjuvant-induced arthritis--II. Effect of antiarthritic therapy on immune function in relation to disease development.

Authors:  S C Gilman; R P Carlson; J F Daniels; L Datko; P R Berner; J Chang; A J Lewis
Journal:  Int J Immunopharmacol       Date:  1987

9.  Macrophage activation in rat models of inflammation and arthritis. Systemic activation precedes arthritis induction and progression.

Authors:  W J Johnson; K A Muirhead; P C Meunier; B J Votta; T C Schmitt; M J DiMartino; N Hanna
Journal:  Arthritis Rheum       Date:  1986-09

10.  Application of a radiometric ear assay for studies of adjuvant arthritis in rats.

Authors:  K R Gans; S Heyner; R F Orzechowski
Journal:  Arthritis Rheum       Date:  1980-06
View more
  6 in total

1.  Immunomodulation of rat antigen-induced arthritis by leflunomide alone and in combination with cyclosporin A.

Authors:  K Thoss; S Henzgen; P K Petrow; D Katenkamp; R Brauer
Journal:  Inflamm Res       Date:  1996-02       Impact factor: 4.575

Review 2.  Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection.

Authors:  R R Bartlett; M Dimitrijevic; T Mattar; T Zielinski; T Germann; E Rüde; G H Thoenes; C C Küchle; H U Schorlemmer; E Bremer
Journal:  Agents Actions       Date:  1991-01

Review 3.  Effects of leflunomide on immune responses and models of inflammation.

Authors:  R R Bartlett; H Anagnostopulos; T Zielinski; T Mattar; R Schleyerbach
Journal:  Springer Semin Immunopathol       Date:  1993

Review 4.  Leflunomide: mode of action in the treatment of rheumatoid arthritis.

Authors:  F C Breedveld; J M Dayer
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

5.  Prednisolone-loaded PLGA microspheres. in vitro characterization and in vivo application in adjuvant-induced arthritis in mice.

Authors:  Khaled A Khaled; Hatem A Sarhan; Mohamed Abbas Ibrahim; Azza H Ali; Youssef W Naguib
Journal:  AAPS PharmSciTech       Date:  2010-05-19       Impact factor: 3.246

6.  Effect of Qianghuo Erhuang Decoction on T Regulatory and T Helper 17 Cells in Treatment of Adjuvant-induced Arthritis in Rats.

Authors:  Can Qian; Mei Kuang; Yong Wang
Journal:  Sci Rep       Date:  2017-12-08       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.